Zoetis Inc. (NYSE:ZTS) Shares Sold by Bennett Selby Investments LP

Bennett Selby Investments LP reduced its stake in shares of Zoetis Inc. (NYSE:ZTS) by 3.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,301 shares of the company’s stock after selling 212 shares during the period. Bennett Selby Investments LP’s holdings in Zoetis were worth $1,036,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ZTS. Global Assets Advisory LLC purchased a new position in shares of Zoetis during the first quarter worth $8,831,000. Franklin Street Advisors Inc. NC lifted its holdings in shares of Zoetis by 4.3% in the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock valued at $20,478,000 after buying an additional 5,035 shares during the period. Prevail Innovative Wealth Advisors LLC lifted its holdings in shares of Zoetis by 24.5% in the 1st quarter. Prevail Innovative Wealth Advisors LLC now owns 18,977 shares of the company’s stock valued at $3,211,000 after buying an additional 3,738 shares during the period. BI Asset Management Fondsmaeglerselskab A S boosted its stake in shares of Zoetis by 58.6% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 41,931 shares of the company’s stock worth $7,095,000 after buying an additional 15,491 shares during the last quarter. Finally, Duality Advisers LP grew its holdings in Zoetis by 43.7% during the first quarter. Duality Advisers LP now owns 40,641 shares of the company’s stock worth $6,877,000 after acquiring an additional 12,359 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. JPMorgan Chase & Co. raised their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. BTIG Research upped their price objective on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Piper Sandler raised their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Finally, Stifel Nicolaus lifted their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Ten investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Zoetis currently has a consensus rating of “Buy” and an average price target of $221.44.

Zoetis Stock Down 0.1 %

NYSE ZTS opened at $190.11 on Friday. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The business’s fifty day simple moving average is $188.07 and its 200-day simple moving average is $176.12. The firm has a market cap of $86.13 billion, a PE ratio of 37.20, a P/E/G ratio of 2.95 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.07. The company had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. Zoetis’s revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.41 EPS. As a group, equities analysts anticipate that Zoetis Inc. will post 5.83 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be paid a dividend of $0.432 per share. The ex-dividend date is Thursday, October 31st. This represents a $1.73 annualized dividend and a yield of 0.91%. Zoetis’s dividend payout ratio (DPR) is 33.86%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.